Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.1B | 10.1B | 9.6B | 9.9B |
| Cost of revenue | 5.5B | 6.3B | 6.3B | 6.3B |
| Gross profit | 2.7B | 3.9B | 3.3B | 3.6B |
| Operating expense | ||||
| Research & development | 123M | 253M | 192M | 189M |
| Selling general and admin | 121M | 183M | 125M | 128M |
| Other operating expenses | 185M | 587M | 244M | 257M |
| Operating income | 2.2B | 2.8B | 2.7B | 3.0B |
| Non operating interest income | ||||
| Income | 56M | 20M | 43M | 3M |
| Expense | 285M | 508M | 272M | 525M |
| Other income expense | 154M | -3.1B | 218M | 350M |
| Pretax income | 2.0B | -901M | 2.7B | 2.7B |
| Tax provision | 647M | -29M | 336M | -34M |
| Net income | 1.4B | -872M | 2.4B | 2.8B |
| Basic EPS | 0.3 | — | 0.6 | 0.7 |
| Diluted EPS | 0.3 | — | 0.6 | 0.7 |
| Basic average shares | 4.3B | — | 4.3B | 4.3B |
| Diluted average shares | 4.3B | — | 4.3B | 4.3B |
| EBITDA | 2.9B | 3.6B | 3.0B | 3.8B |
| Net income from continuing op. | 2.0B | -901M | 2.7B | 2.7B |
| Minority interests | -2M | 178M | 21M | 0 |
| Preferred stock dividends | — | — | — | — |